Skip to main content
enVVeno Medical Corp logo

enVVeno Medical Corp — Investor Relations & Filings

Ticker · NVNO ISIN · US29415J1060 US Manufacturing
Open in API
Filings indexed 396 across all filing types
Latest filing 2026-04-29 Regulatory Filings
Country US United States of America
Listing US NVNO

About enVVeno Medical Corp

https://envveno.com/

enVVeno Medical Corp. is a late clinical-stage medical device company that develops bioprosthetic, tissue-based solutions to treat deep venous disease. The company's primary focus is on Chronic Venous Insufficiency (CVI), a condition resulting from damaged valves in the leg veins that causes insufficient blood return to the heart. Its portfolio of investigational products includes the VenoValve®, a surgical replacement venous valve, and the enVVe®, a next-generation, non-surgical, transcatheter-based replacement venous valve. Both product candidates are designed for the treatment of CVI in the deep veins and are currently in clinical development.

Recent filings

Filing Released Lang Actions
8-K - enVVeno Medical Corp (0001661053) (Filer)
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report pursuant to the Securities Exchange Act of 1934. It reports a significant event: FDA approval of an IDE application for a pivotal study of a medical device, along with financial condition information as of March 31, 2026. The document includes a press release as an exhibit and forward-looking statements. It does not contain comprehensive financial statements or detailed financial analysis typical of Annual Reports (10-K) or Interim Reports (IR). It is not an earnings release, management discussion, or a proxy statement. The Form 8-K is a regulatory filing used to report material events promptly. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length (8311 characters) and content confirm it is a full filing, not just a brief announcement or certification.
2026-04-29 English
S-8 - enVVeno Medical Corp (0001661053) (Filer)
Capital/Financing Update Classification · 95% confidence The document is a Form S-8 Registration Statement filed with the SEC, which is used to register securities to be offered under employee benefit plans, specifically the Amended and Restated 2016 Omnibus Incentive Plan. It includes a prospectus for resale of shares by certain stockholders, including directors and officers, under the plan. The document is a registration and offering statement related to employee stock plans, not a financial report, earnings release, or management discussion. It is a capital markets filing related to securities registration and issuance under an employee incentive plan. This type of filing corresponds to a capital/financing update category rather than an annual report, earnings release, or other categories. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is a full registration statement, not a brief announcement or certification, supporting high confidence in classification.
2026-03-26 English
10-K - enVVeno Medical Corp (0001661053) (Filer)
Annual Report FY 2025
2026-03-26 English
SCHEDULE 13G/A Filing
Major Shareholding Notification
2026-02-17 English
SCHEDULE 13G Filing
Major Shareholding Notification
2026-02-10 English
SCHEDULE 13G Filing
Major Shareholding Notification
2026-02-10 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.